|
COST
|
Consumer Defensive |
Morgan Stanley |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$486.8B
|
$167.07
|
-4.8%
|
-6.0%
|
-1.6%
|
+1.5%
|
+0.6%
|
-0.4%
|
|
AMGN
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$179.7B
|
$186.85
|
-0.2%
|
-0.6%
|
-0.2%
|
+0.2%
|
-0.9%
|
-0.8%
|
|
GILD
|
Healthcare |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$163.8B
|
$83.51
|
-0.7%
|
-1.6%
|
-0.2%
|
+1.3%
|
-0.6%
|
-1.5%
|
|
SPGI
|
Financial Services |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$125.2B
|
$159.04
|
+0.2%
|
-0.4%
|
+0.5%
|
-0.2%
|
+0.1%
|
+1.3%
|
|
DHR
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$118.8B
|
$77.09
|
+0.0%
|
+0.8%
|
-0.7%
|
+0.2%
|
-0.2%
|
+0.1%
|
|
MCO
|
Financial Services |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$78.2B
|
$142.10
|
+0.2%
|
+0.3%
|
-0.4%
|
+0.1%
|
+0.3%
|
+1.0%
|
|
REGN
|
Healthcare |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$68.5B
|
$463.40
|
-0.0%
|
+1.4%
|
-0.1%
|
-1.8%
|
-1.8%
|
-1.3%
|
|
A
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$32.3B
|
$65.70
|
-0.0%
|
+1.0%
|
+0.3%
|
+0.1%
|
+0.0%
|
+1.4%
|
|
NTRA
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$26.8B
|
$13.56
|
+2.1%
|
+5.5%
|
-7.4%
|
+0.5%
|
-1.1%
|
+1.6%
|
|
STZ
|
Consumer Defensive |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$25.7B
|
$209.25
|
+0.0%
|
+0.4%
|
-0.9%
|
-0.1%
|
-0.1%
|
-0.2%
|
|
MTD
|
Healthcare |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$21.7B
|
$644.85
|
-0.3%
|
+0.1%
|
+1.0%
|
+0.2%
|
+1.0%
|
+0.1%
|
|
WAT
|
Healthcare |
Morgan Stanley |
Maintains
|
Underweight
→
Underweight
|
—
|
$19.9B
|
$183.95
|
-0.2%
|
+1.0%
|
-1.1%
|
+0.7%
|
+0.4%
|
+0.1%
|
|
ALGN
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$11.9B
|
$186.61
|
+0.2%
|
+0.2%
|
+0.6%
|
+0.3%
|
+2.0%
|
-0.0%
|
|
BMRN
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$9.9B
|
$94.42
|
-0.1%
|
+0.4%
|
+0.2%
|
-0.7%
|
+0.6%
|
+0.2%
|
|
CYTK
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$9.2B
|
$15.45
|
+3.2%
|
+0.3%
|
-0.6%
|
+0.3%
|
+1.0%
|
+0.3%
|
|
HAE
|
Healthcare |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$2.9B
|
$46.38
|
+0.1%
|
-0.2%
|
-0.7%
|
-0.5%
|
+0.9%
|
-0.3%
|
|
RARE
|
Healthcare |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$2.2B
|
$55.81
|
-0.2%
|
-2.7%
|
-0.9%
|
+0.4%
|
+1.6%
|
-0.8%
|
|
XRAY
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$1.9B
|
$58.98
|
-0.1%
|
-0.8%
|
-0.7%
|
-0.9%
|
-0.4%
|
+1.9%
|
|
INVA
|
Healthcare |
Morgan Stanley |
Maintains
|
Underweight
→
Underweight
|
—
|
$1.8B
|
$14.75
|
+0.0%
|
-2.9%
|
-1.1%
|
-1.6%
|
-0.8%
|
+0.5%
|
|
GLPG
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$1.8B
|
$102.60
|
-0.9%
|
-0.9%
|
+0.9%
|
+1.4%
|
-0.2%
|
-0.5%
|